ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2021

Efavirenz as a potential drug for the treatment of triple-negative breast cancers.

P-T Chiou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.